Synthetic Blood International, Inc. Release: Oxycyte(R) Treatment for Traumatic Brain Injury Featured in Miami Herald Article
2008-03-18
COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) lead product Oxycyte® is the subject of an article in today’s Miami Herald. The article appears in the paper’s health section under the headline: “Artificial blood goes from science fiction to science fact.” Oxycyte is the company’s perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
适应症
靶点
-药物
热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。